Arcadis NV ARCAY Company Overview  Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Arcadis NV ARCAY Company Overview 

Stock Message Board http://investorshangout.com/search?q=ARCAY&am...mp;yt1=Go!

Arcadis NV ARCAY Current Price and Quotes
Last Price 26.90
Previous Close 26.90 Open N/A
Daily Range N/A - N/A 52wk Range 43.00 - 20.00
Volume 0 Dividend 0.5734
Average Vol (3m) 595 Yield 2.1316
Arcadis NV ARCAY
Company Information

Gustav Mahlerplein 97-103
PO Box 7895
Amsterdam 1082 MS
Netherlands

Website: http://www.arcadis.com
Phone: +31-202011083
Email: ir@arcadis.com

Arcadis NV ARCAY
ARCADIS is an international company providing consultancy, engineering and management services in infrastructure,water, environment and buildings, to enhance mobility, sustainability and quality of life. ARCADIS develops, designs, implements, maintains and operates projects for companies and governments. With more than 21,000 employees and EUR 2.4 billion in gross revenue, the company has an extensive international network that is supported by strong local market positions.

Arcadis NV ARCAY
Financial Reportings and Disclosures

Reporting Status International Reporting: Euronext Amsterdam
CIK 0000913596
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data

SIC - Industry Classification 1623 - Water, sewer, and utility lines
Incorporated In: Netherlands
Year of Inc. Not Available
Employees 12000 a/o
Company Officers/Contacts

Neil McArthur CEO
Renier Vree CFO
Company Directors

Not Available
Company Notes

Formerly=Heidemij N V until 12-97
US Address: 88 Duryea Road, Melville, NY 11747. U.S. Phone #: 516-391-5262
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Arcadis NV ARCAY
ARCAY Security Details Other Company Securities

Share Structure

Market Value1 $1,820,489,511 a/o Sep 27, 2013
Shares Outstanding 67,676,190 a/o Dec 31, 2010
Float Not Available
Authorized Shares Not Available
Par Value  0.05
Shareholders

Shareholders of Record 121 a/o May 17, 2007
Corporate Actions

Ex. Date Record Date Pay Date
Dividend (0.57336) May 09, 2013 May 13, 2013 Jun 03, 2013
Dividend (0.57433) May 09, 2013 May 13, 2013 Jun 03, 2013
Dividend (0.51104) May 18, 2012 May 22, 2012 May 31, 2012
Security Notes

Note=6-8-07 deleted from NASDAQ
Capital Change=Stk. Div.=200%. Ex-date=05/22/2008. Rec date=05/15/2008. Pay date=05/21/2008.
Non US Stock Exchange Listing

ARCAD - Euronext Amsterdam - Qualified
Short Selling Data

Short Interest 0 (-100%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

BNY Mellon

Arcadis NV ARCAY Recent News

Sept 16, 2013 New York City Health and Hospitals Corporation hires ARCADIS to assess risks and design systems to reduce flood damage from future severe weather events
Sept 9, 2013 ARCADIS WINS PROJECT AND PROGRAM MANAGEMENT FOR THE MAJOR GRAND PARIS METRO PROJECT IN PARIS REGION, FRANCE
Sept 3, 2013 Croon Elektrotechniek and ARCADIS working together on bridges and locks design and maintenance upgrades in Ijsselmeer area
Aug 26, 2013 ARCADIS and Philips sign worldwide project management contract
Jul 31, 2013 ARCADIS improves organic revenue growth in second quarter 2013 while maintaining margins
Jul 8, 2013 BP appoints ARCADIS to global frameworks for environment and response planning services
Jul 1, 2013 ARCADIS refinances bank debt through U.S. Private Placement


Arcadis NV ARCAY Financials
Data is unavailable at this time. Please check this page later.


ARCAY Arcadis NV Research DD Guide

Stock Message Board http://investorshangout.com/search?q=ARCAY&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ARCAY/quote
Stock Chart http://www.otcmarkets.com/stock/ARCAY/chart
Company Info http://www.otcmarkets.com/stock/ARCAY/company-info
Recent News http://www.otcmarkets.com/stock/ARCAY/news
Financials http://www.otcmarkets.com/stock/ARCAY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ARCAY/filings
Short Sales http://www.otcmarkets.com/stock/ARCAY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ARCAY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ARCAY/research
Summary http://finance.yahoo.com/q?s=ARCAY
Historical Prices http://finance.yahoo.com/q/hp?s=ARCAY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ARCAY
Basic Chart http://finance.yahoo.com/q/bc?s=ARCAY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ARCAY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ARCAY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ARCAY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ARCAY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ARCAY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ARCAY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ARCAY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ARCAY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ARCAY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ARCAY
Balance Sheet http://finance.yahoo.com/q/bs?s=ARCAY
Cash Flow http://finance.yahoo.com/q/cf?s=ARCAY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ARCAY
Market Watch http://www.marketwatch.com/investing/stock/ARCAY
Bloomberg http://www.bloomberg.com/quote/ARCAY:US
Morningstar http://quotes.morningstar.com/stock/s?t=ARCAY
Bussinessweek http://investing.businessweek.com/research/st...cker=ARCAY
Barchart http://www.barchart.com/quotes/stocks/ARCAY
OTC Short Report http://otcshortreport.com/index.php?index=ARCAY
Investopedia http://www.investopedia.com/markets/stocks/ARCAY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading